Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and non-destructive. The description adds significant behavioral context: data sources (SEC EDGAR/XBRL for companies, FAERS/clinical trials for drugs), how fiscal years are handled, sorting by primary metric, and return format with citation URIs. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with example queries and key advice. While it is somewhat long, every sentence adds value (purpose, data sources, formatting, sorting, comparison benefit). A slight reordering or trimming could improve conciseness, but it is well-structured for readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's moderate complexity (2 params, no output schema), the description covers purpose, usage, data sources, parameter semantics, and expected behavior. It explains return format (paired data + citation URIs) and sorting, which compensates for lack of output schema. However, it could mention any limitations or error conditions.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description provides rich additional meaning: explains what data each 'type' fetches (e.g., 'company' pulls revenue, net income, cash, long-term debt), how to format values (tickers/CIKs for company, drug names for drug), and constraints (2-5 items). This goes well beyond the schema's minimal descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs in a single call, using verbs like 'compare', 'rank', and specifying the resource (entities). It distinguishes itself from potential siblings like 'entity_profile' by emphasizing parallel vs sequential lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing clear guidance. It also notes it replaces 8-15 sequential lookups, implying efficiency. However, it does not explicitly list when NOT to use it or mention specific sibling tools as alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation5/5

Each tool has a clearly distinct purpose. Tools like ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are differentiated by reliability mode; entity_profile vs compare_entities serve single vs multi-entity; and memorization, subscription, and search tools occupy separate operational niches. No two tools could be easily confused.

Naming Consistency2/5

Tool names follow no consistent pattern. Some use verb_noun (ask_pipeworx, resolve_entity, validate_claim), others are noun phrases (polymarket_arbitrage, ai_visibility_check), and some mix verb+noun with underscores inconsistently (generate_llms_txt, scan_competitor_ai_presence). This lack of uniformity makes the surface harder to navigate.

Tool Count3/5

34 tools is borderline high. The server spans multiple domains (data query, prediction markets, eLife, memory, subscriptions), and each domain gets several tools, making the overall surface feel bloated. While individual tools are justified, the total count strains discoverability and hints at scope creep.

Completeness2/5

The tool set is incomplete relative to its stated breadth. For a server named 'Elife', only 3 tools actually serve eLife; the rest are dominated by Pipeworx and Polymarket. Within the query/data domain, coverage is deep but lacks write/modify tools. Prediction market analysis lacks execution tools (no order placement). This leaves clear gaps for agents that need to act on the data.